Clinical Trials for Prinicipal Investigator: David Imagawa

4 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-03-03 Immunologic Factors Affecting Outcomes in Patients with Liver Cancer Open
UCI-16-40 An Open-Label Multicenter Phase I Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Subjects with Advanced Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma Open
UCI-17-89 A Randomized, Open-label, Multicenter Phase 3 Study to Compare the Efficacy and Safety of BGB-A317 versus Sorafenib as First-Line Treatment in Patients with Unresectable Hepatocellular Carcinoma Open
UCI-18-29 Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma Open